Roche PC - Search Results

1

Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.

Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD. Witzig TE, et al. Among authors: roche pc. Clin Cancer Res. 2002 May;8(5):1085-91. Clin Cancer Res. 2002. PMID: 12006523

2

Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.

Reinholz MM, Nibbe A, Jonart LM, Kitzmann K, Suman VJ, Ingle JN, Houghton R, Zehentner B, Roche PC, Lingle WL. Reinholz MM, et al. Among authors: roche pc. Clin Cancer Res. 2005 May 15;11(10):3722-32. doi: 10.1158/1078-0432.CCR-04-1483. Clin Cancer Res. 2005. PMID: 15897569

3

Molecular markers in male breast carcinoma.

Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, Donohue JH. Rayson D, et al. Among authors: roche pc. Cancer. 1998 Nov 1;83(9):1947-55. doi: 10.1002/(sici)1097-0142(19981101)83:9<1947::aid-cncr10>3.0.co;2-j. Cancer. 1998. PMID: 9806653

4

Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol.

Hartmann LC, Ingle JN, Wold LE, Farr GH Jr, Grill JP, Su JQ, Maihle NJ, Krook JE, Witzig TE, Roche PC. Hartmann LC, et al. Among authors: roche pc. Cancer. 1994 Dec 1;74(11):2956-63. doi: 10.1002/1097-0142(19941201)74:11<2956::aid-cncr2820741111>3.0.co;2-v. Cancer. 1994. PMID: 7954259 Clinical Trial.

5

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831.

Roche PC, Suman VJ, Jenkins RB, Davidson NE, Martino S, Kaufman PA, Addo FK, Murphy B, Ingle JN, Perez EA. Roche PC, et al. J Natl Cancer Inst. 2002 Jun 5;94(11):855-7. doi: 10.1093/jnci/94.11.855. J Natl Cancer Inst. 2002. PMID: 12048274

6

Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.

Reinholz MM, Iturria SJ, Ingle JN, Roche PC. Reinholz MM, et al. Among authors: roche pc. Breast Cancer Res Treat. 2002 Jun;74(3):255-69. doi: 10.1023/a:1016339120506. Breast Cancer Res Treat. 2002. PMID: 12206515

7

Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue.

Reinholz MM, An MW, Johnsen SA, Subramaniam M, Suman VJ, Ingle JN, Roche PC, Spelsberg TC. Reinholz MM, et al. Among authors: roche pc. Breast Cancer Res Treat. 2004 Jul;86(1):75-88. doi: 10.1023/B:BREA.0000032926.74216.7d. Breast Cancer Res Treat. 2004. PMID: 15218362

8

Prognostic value of bone marrow angiogenesis in multiple myeloma.

Rajkumar SV, Leong T, Roche PC, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Kyle RA, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: roche pc. Clin Cancer Res. 2000 Aug;6(8):3111-6. Clin Cancer Res. 2000. PMID: 10955791

9

17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes.

Wu GJ, Sinclair CS, Paape J, Ingle JN, Roche PC, James CD, Couch FJ. Wu GJ, et al. Among authors: roche pc. Cancer Res. 2000 Oct 1;60(19):5371-5. Cancer Res. 2000. PMID: 11034073

10

Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.

Wu G, Sinclair C, Hinson S, Ingle JN, Roche PC, Couch FJ. Wu G, et al. Among authors: roche pc. Cancer Res. 2001 Jul 1;61(13):4951-5. Cancer Res. 2001. PMID: 11431322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters